Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer

Introduction Immune checkpoint blockers (ICBs) revolutionized the treatment of patients with advanced non-small cell lung cancer (NSCLC) but only a fraction of them obtain a response, and clinical benefit from these treatments is often difficult to predict. The aim of our study is to unveil the pote...

Full description

Saved in:
Bibliographic Details
Main Authors: Francois-Xavier Danlos, Aurélien Marabelle, Tyler Hulett, Fabrice Barlesi, Benjamin Besse, David Planchard, Nathalie Chaput-Gras, Mihaela Aldea, Filippo G Dall’Olio, Paul-Henry Cournède, Quentin Blampey, Wael Salem Zrafi, Matthieu Roulleaux-Dugage, Gabriel Roman, Charles Naltet, Daniel Gautheret
Format: Article
Language:English
Published: BMJ Publishing Group 2024-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/11/e009931.full
Tags: Add Tag
No Tags, Be the first to tag this record!